Objective: To investigate how an AI case-finding and clinical coaching intervention impacted mortality and how this impact varied by age, gender, and deprivation status. Design: Multi-site parallel prospective two-arm Randomised Controlled Trial led by Nuffield Trust and delivered by HN (Health Navigator Ltd). Patients were randomised on a 2:1 ratio to the intervention after consent and the automated and manual screening processes. Setting: Secondary care-based patient identification for a community-based intervention; Eight hospital sites across England were enrolled onto the study (York, Staffordshire, Essex, and Kent). Participants: Subjects aged 18 and over, who have experienced at least one emergency attendance in the preceding six months and identified as high-risk of unplanned hospitalisation via a prediction model. Subjects were also manually screened for their suitability to intervention. Intervention: One-to-one telephone-based health coaching, led by registered nurses or paramedics. Primary outcome measure: 24-month mortality. Results: The intervention was associated with reduced overall mortality (posterior probability: 92.2%), predominantly driven by the impact for males aged 75 and over (log-rank p-value: 0.0011, Hazard Ratio (HR) [95% CI]: 0.57 [0.37, 0.84], number needed to treat: 8). Excluding one site unable to adopt the prediction model indicated stronger impact (HR [95% CI]: 0.45 [0.26, 0.76]), suggesting a role of prediction in reducing mortality. Conclusions: Early mortality, specifically in elderly males, may be prevented by predicting individuals at risk of unplanned hospitalisation and supporting them with a clear outreach, out-of-hospital nurse-led, telephone-based coaching and care model. Trial registration: IRAS project ID: 173319; and clinicaltrials.gov ID: 2015-000810-23
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.